AiCuris Anti-infective Cures AG

AiCuris - founded in 2006 – is an infectious diseases specialist. Its focus comprise discovery, research and development of novel antiviral and antibacterial agents in the indications Human Cytomegalovirus, Herpes simplex virus, Hepatitis B virus, and (multi)resistant bacterial infections treated in the hospital. With its highly innovative pipeline AiCuris addresses mostly specialist markets and severe, potentially life threatening infections with high medical need. A major success of the company was the license deal with Merck & Co. (MSD).